Product
BR1016A
1 clinical trial
1 indication
Indication
Chronic Heart FailureClinical trial
A Randomized, Open-label, Single Dose, Two-way Crossover Phase 1 Study to Evaluate the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-12-14